Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients
about
Diabetes-induced mechanophysiological changes in the small intestine and colon.Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies.Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis.Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
P2860
Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@ast
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@en
type
label
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@ast
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@en
prefLabel
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@ast
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@en
P2093
P2860
P356
P1476
Impact of Diabetes Status and ...... Stage II Colon Cancer Patients
@en
P2093
Iain Skinner
Jeanne Tie
Kathryn Field
Peter Gibbs
Spiros Fourlanos
Suzanne Kosmider
P2860
P304
P356
10.1155/2015/189132
P577
2015-05-05T00:00:00Z